2025 annual financial data
Theravance Biopharma 2025 Operating margin
Theravance Biopharma 2025 operating margin with verified reported values.
Direct answer
Operating margin was -12.33%.
Operating income was -13,246,000 USD and net income was 105,895,000 USD.
Operating cash flow was 238,541,000 USD.
Get free Theravance Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 107,464,000 USD
- Operating income
- -13,246,000 USD
- Net income
- 105,895,000 USD
- Operating cash flow
- 238,541,000 USD